psalexa
logo

Drug of Abuse Testing Market

Drug of Abuse (DOA) Testing Market by Product (Rapid Test Kits, Assay Kits & Reagents, Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers), by Sample Type (Urine, Saliva, Hair), by End User (Hospital, Laboratory, At Home, Workplace), by Geography (U.S., U.K., Germany, France, Italy, Japan, China, India, Brazil) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Published: September 2017
Report Code: LS10038
Available Format:
Pages: 188
Category : Healthcare

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Sample Type

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Market Segmentation

4.1.1 By Product

4.1.1.1 Consumable

4.1.1.1.1 Rapid test kits

4.1.1.1.2 Assay kits & reagents

4.1.1.1.3 Others

4.1.1.2 Equipment

4.1.1.2.1 Immunoassay analyzers

4.1.1.2.2 Chromatography instruments

4.1.1.2.3 Breath analyzers

4.1.2 By Sample Type

4.1.2.1 Urine

4.1.2.2 Saliva

4.1.2.3 Hair

4.1.2.4 Others

4.1.3 By End User

4.1.3.1 Hospitals

4.1.3.2 Laboratories

4.1.3.3 Workplace

4.1.3.4 At home

4.1.3.5 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Mergers & acquisitions

4.2.1.2 Increasing number of product launches

4.2.2 Drivers

4.2.2.1 Increased use of drug of abuse testing at organizational level

4.2.2.2 Increased production and trade of illicit drugs worldwide

4.2.2.3 Global increase in road accidents and death rates

4.2.2.4 Increase in consumption of illegal drugs

4.2.2.5 Technological advancements in drug of abuse testing market

4.2.2.6 Initiatives by government and other organizations to reduce  drug abuse levels

4.2.2.7 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Legalization of illicit drugs

4.2.3.2 Social issues associated with drug of abuse testing

4.2.3.3 Inability to detect low-dose designer drugs

4.2.3.4 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Threat of New Entrants

4.3.4 Intensity of Rivalry

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 Global Drug of Abuse Testing Market, by Product

5.1.1 Global Drug of Abuse Testing Consumable Market, by Type

5.1.2 Global Drug of Abuse Testing Equipment Market, by Type

5.2 Global Drug of Abuse Testing Market, by Sample Type

5.3 Global Drug of Abuse Testing Market, by End User

5.4 Global Drug of Abuse Testing Market, by Region

Chapter 6. North America Market Size and Forecast

6.1 North America Drug of Abuse Testing Market

6.1.1 North America Drug of Abuse Testing Market, by Product

6.1.1.1 North America drug of abuse testing consumable market, by  type

6.1.1.2 North America drug of abuse testing equipment market, by  type

6.1.2 North America Drug of Abuse Testing Market, by Sample Type

6.1.3 North America Drug of Abuse Testing Market, by End User

6.1.4 North America Drug of Abuse Testing Market, by Country

Chapter 7. Europe Market Size and Forecast

7.1 Europe Drug of Abuse Testing Market

7.1.1 Europe Drug of Abuse Testing Market, by Product

7.1.1.1 Europe drug of abuse testing consumable market, by type

7.1.1.2 Europe drug of abuse testing equipment market, by type

7.1.2 Europe Drug of Abuse Testing Market, by Sample Type

7.1.3 Europe Drug of Abuse Testing Market, by End User

7.1.4 Europe Drug of Abuse Testing Market, by Country

Chapter 8. Asia–Pacific Market Size and Forecast

8.1 Asia-Pacific Drug of Abuse Testing Market

8.1.1 Asia-Pacific Drug of Abuse Testing Market, by Product

8.1.1.1 Asia-Pacific drug of abuse testing consumable market, by type

8.1.1.2 Asia-Pacific drug of abuse testing equipment market, by type

8.1.2 Asia-Pacific Drug of Abuse Testing Market, by Sample Type

8.1.3 Asia-Pacific Drug of Abuse Testing Market, by End User

8.1.4 Asia-Pacific Drug of Abuse Testing Market, by Country

Chapter 9. Rest of the World Market Size and Forecast

9.1 Rest of the World (RoW) Drug of Abuse Testing Market

9.1.1 RoW Drug of Abuse Testing Market, by Product

9.1.1.1 RoW drug of abuse testing consumable market, by type

9.1.1.2 RoW drug of abuse testing equipment market, by type

9.1.2 RoW Drug of Abuse Testing Market, by Sample Type

9.1.3 RoW Drug of Abuse Testing Market, by End User

9.1.4 RoW Drug of Abuse Testing Market, by Country

Chapter 10. Competitive Landscape

10.1 Product Benchmarking of Key Players

10.2 Global Strategic Developments of Key Players

10.2.1 Merger and Acquisition

10.2.2 Product Launch/Approval

10.2.3 Partnership

10.2.4 Other Developments

Chapter 11. Company Profiles

11.1 Danaher Corporation

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.1.3 Key Financial Summary

11.1.4 Strategic Growth Plans

11.2 Siemens AG

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.2.3 Key Financial Summary

11.2.4 Strategic Growth Plans

11.3 Merck KGaA

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.3.3 Key Financial Summary

11.3.4 Strategic Growth Plans

11.4 Shimadzu Corporation

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.4.3 Key Financial Summary

11.4.4 Strategic Growth Plans

11.5 Drägerwerk AG & Co. KGaA

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.5.3 Key Financial Summary

11.5.4 Strategic Growth Plans

11.6 Express Diagnostics Int'l, Inc.

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.6.3 Strategic Growth Plans

11.7 bioMérieux S.A.

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.7.3 Key Financial Summary

11.7.4 Strategic Growth Plans

11.8 Waters Corporation

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.8.3 Key Financial Summary

11.8.4 Strategic Growth Plans

11.9 Roche Holding AG

11.9.1 Business Overview

11.9.2 Product and Service Offerings

11.9.3 Key Financial Summary

11.9.4 Strategic Growth Plans

11.10 Quest Diagnostics Inc.

11.10.1 Business Overview

11.10.2 Product and Service Offerings

11.10.3 Key Financial Summary

11.10.4 Strategic Growth Plans

11.11 Laboratory Corporation of America Holdings

11.11.1 Business Overview

11.11.2 Products and Service Offerings

11.11.3 Key Financial Summary

11.11.4 Strategic Growth Plans

11.12 Alere Inc.

11.12.1 Business Overview

11.12.2 Product and Service Offerings

11.12.3 Strategic Growth Plans

11.13 Abbott Laboratories

11.13.1 Business Overview

11.13.2 Product and Service Offerings

11.13.3 Key Financial Summary

11.13.4 Strategic Growth Plans

11.14 Randox Laboratories Ltd

11.14.1 Business Overview

11.14.2 Product and Service Offerings

11.14.3 Strategic Growth Plans

11.15 Psychemedics Corporation

11.15.1 Business Overview

11.15.2 Product and Service Offerings

11.15.3 Key Financial Summary

11.15.4 Strategic Growth Plans

11.16 Bio-Rad Laboratories, Inc.

11.16.1 Business Overview

11.16.2 Product and Service Offerings

11.16.3 Key Financial Summary

11.16.4 Strategic Growth Plans

11.17 Sonic Healthcare Ltd.

11.17.1 Business Overview

11.17.2 Product and Service Offerings

11.17.3 Key Financial Summary

11.17.4 Strategic Growth Plans

11.18 ThermoFisher Scientific Inc.

11.18.1 Business Overview

11.18.2 Product and Services

11.18.3 Key Financial Summary

11.18.4 Strategic Growth Plans

Chapter 12. Appendix

12.1 Abbreviations

 

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 GLOBAL DRUG OF ABUSE TESTING MARKET SNAPSHOT

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 6 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 7 GLOBAL DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 8 GLOBAL DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 9 GLOBAL DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 10 GLOBAL DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 11 GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 12 GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 13 GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 14 GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER $M (2017 – 2023)

TABLE 15 GLOBAL DRUG OF ABUSE TESTING MARKET, BY REGION, $M (2013 – 2016)

TABLE 16 GLOBAL DRUG OF ABUSE TESTING MARKET, BY REGION, $M (2017 – 2023)

TABLE 17 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 18 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 19 NORTH AMERICA DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 20 NORTH AMERICA DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 21 NORTH AMERICA DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 22 NORTH AMERICA DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 23 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 24 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 25 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 26 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 27 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 28 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 29 EUROPE DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 30 EUROPE DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 31 EUROPE DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 32 EUROPE DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 33 EUROPE DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 34 EUROPE DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 35 EUROPE DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 36 EUROPE DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 37 EUROPE DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 38 EUROPE DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 39 EUROPE DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 40 EUROPE DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 41 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 42 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 43 ASIA-PACIFIC DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 44 ASIA-PACIFIC DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 45 ASIA-PACIFIC DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 46 ASIA-PACIFIC DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 47 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 48 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 49 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 50 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 51 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 52 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 53 ROW DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 54 ROW DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 55 ROW DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 56 ROW DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 57 ROW DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 58 ROW DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 59 ROW DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 60 ROW DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 61 ROW DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 62 ROW DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 63 ROW DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 64 ROW DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 65 DANAHER CORPORATION– AT A GLANCE

TABLE 66 DANAHER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 67 SIEMENS AG – AT A GLANCE

TABLE 68 SIEMENS AG – KEY FINANCIAL SUMMARY

TABLE 69 MERCK KGAA – AT A GLANCE

TABLE 70 MERCK KGAA – KEY FINANCIAL SUMMARY

TABLE 71 SHIMADZU CORPORATION – AT A GLANCE

TABLE 72 SHIMADZU CORPORATION – KEY FINANCIAL SUMMARY

TABLE 73 DRÄGERWERK AG & CO. KGAA– AT A GLANCE

TABLE 74 DRAGERWERK AG & CO. KGAA – KEY FINANCIAL SUMMARY

TABLE 75 EXPRESS DIAGNOSTICS INT'L, INC.– AT A GLANCE

TABLE 76 BIOMÉRIEUX S.A. – AT A GLANCE

TABLE 77 BIOMÉRIEUX S.A. – KEY FINANCIAL SUMMARY

TABLE 78 WATERS CORPORATION – AT A GLANCE

TABLE 79 WATERS CORPORATION – KEY FINANCIAL SUMMARY

TABLE 80 ROCHE HOLDING AG – AT A GLANCE

TABLE 81 ROCHE HOLDING AG – KEY FINANCIAL SUMMARY

TABLE 82 QUEST DIAGNOSTICS INC.– AT A GLANCE

TABLE 83 QUEST DIAGNOSTICS INC. – KEY FINANCIAL SUMMARY

TABLE 84 LABORATORY CORPORATION OF AMERICA HOLDINGS – AT A GLANCE

TABLE 85 LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FINANCIAL SUMMARY

TABLE 86 ALERE INC. – AT A GLANCE

TABLE 87 ABBOTT LABORATORIES – AT A GLANCE

TABLE 88 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY

TABLE 89 RANDOX LABORATORIES LTD. – AT A GLANCE

TABLE 90 PSYCHEMEDICS CORPORATION – AT A GLANCE

TABLE 91 PSYCHEMEDICS CORPORATION – KEY FINANCIAL SUMMARY

TABLE 92 BIO-RAD LABORATORIES, INC.– AT A GLANCE

TABLE 93 BIO-RAD LABORATORIES, INC. – KEY FINANCIAL SUMMARY

TABLE 94 SONIC HEALTHCARE LTD.– AT A GLANCE

TABLE 95 SONIC HEALTHCARE LTD. – KEY FINANCIAL SUMMARY

TABLE 96 THERMOFISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 97 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

  

LIST OF FIGURES

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 PORTER’S FIVE FORCES ANALYSIS

FIG 9 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT (2016)

FIG 10 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 11 GLOBAL DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 12 GLOBAL DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 13 GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 14 GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER $M (2013 – 2023)

FIG 15 WORLDWIDE MAJOR MARKETS FOR GLOBAL DRUG OF ABUSE TESTING

FIG 16 NORTH AMERICA DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 17 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 18 NORTH AMERICA DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 19 NORTH AMERICA DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 20 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 21 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 22 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 23 EUROPE DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 24 EUROPE DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 25 EUROPE DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 26 EUROPE DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 27 EUROPE DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 28 EUROPE DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 29 EUROPE DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 30 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 31 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 32 ASIA-PACIFIC DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 33 ASIA-PACIFIC DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 34 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 35 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 36 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 37 ROW DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 38 ROW DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 39 ROW DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 40 ROW DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 41 ROW DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 42 ROW DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 43 ROW DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 44 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 45 DANAHER CORPORATION REVENUE SPLIT BY SEGMENT (2016)

FIG 46 DANAHER CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 47 SIEMENS AG REVENUE SPLIT BY SEGMENT (2016)

FIG 48 SIEMENS AG REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 49 MERCK KGAA REVENUE SPLIT BY SEGMENT (2016)

FIG 50 MERCK KGAA REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 51 SHIMADZU CORPORATION REVENUE SPLIT BY SEGMENT (2016)

FIG 52 SHIMADZU CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 53 DRAGERWERK AG & CO. KGAA REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 54 BIOMÉRIEUX SA REVENUE SPLIT BY APPLICATION (2016)

FIG 55 BIOMÉRIEUX SA REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 56 WATERS CORPORATION REVENUE SPLIT BY SEGMENT (2016)

FIG 57 WATERS CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 58 ROCHE HOLDING AG REVENUE SPLIT BY SEGMENT (2016)

FIG 59 QUEST DIAGNOSTICS INC. REVENUE SPLIT BY SEGMENT (2016)

FIG 60 LABORATORY CORPORATION OF AMERICA HOLDINGS REVENUE SPLIT BY SEGMENT (2016)

FIG 61 LABORATORY CORPORATION OF AMERICA HOLDINGS REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 62 PSYCHEMEDICS CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 63 BIO-RAD LABORATORIES, INC. REVENUE SPLIT BY SEGMENT (2016)

FIG 64 BIO-RAD LABORATORIES, INC. REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 65 SONIC HEALTHCARE LTD. REVENUE SPLIT BY SEGMENT (2016)

FIG 66 SONIC HEALTHCARE LTD. REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 67 THERMOFISHER SCIENTIFIC INC. REVENUE SPLIT BY SEGMENT (2016)

FIG 68 THERMOFISHER SCIENTIFIC INC. REVENUE SPLIT BY GEOGRAPHY (2016)

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry